Opioid Overdose Crisis: Widening the Lens
Mary Greeley Medical Center Grand Rounds is a multi-disciplinary clinical activity which serves to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public or the profession.
Physicians, Advance Practice Professionals, Nurses, Ancillary Staff, Medical Students (rotating), Non-Medical Students (rotating), and Healthcare Administrators.
- The potential synthetic opioid fentanyl and its derivatives, which are increasingly laced into heroin and other street drugs, is driving the rapid rise in opioid overdose deaths. People who use street drugs often don't even know they've taken fentanyl. Many laboratories do not test for fentanyl or its analogs. Amid the opioid crisis, new data shows that fatalities tied to cocaine and methamphetamine are also surging. Hardest hit in the recent stimulant overdose death scourge include some Midwestern states. Other new substances are emerging on the drug scene. Broader awareness of emerging drugs threats and how they intersect with the opioid overdose crisis will help the healthcare community better recognize drugs that are being abused, their clinical effects and appropriate treatments.
- Describe the scope of the opioid abuse and overdose epidemic including the recent surge in overdose deaths related to illicitly manufactured fentanyl derivatives.
- Recognize the rising number of overdose deaths from a deadly combination of opioids and other drugs.
- Identify new and emerging drugs of abuse, nature and route of ingestion, range of effects, toxicity, detection methods and legal considerations.
- Describe the approach taken by toxicologists/poison centers toward the management of overdose and drug toxicity.
Linda Kalin, RN, BS, CPSI
Executive Director, Iowa Poison Control
- Ms. Kalin indicates she has no relationships with a commercial entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by or used on patients.
- No member of the Mary Greeley Medical Center CME Committee who planned this activity has any financial relationship to disclose relating to the content.
This program is supported by gifts to the Mary Greeley Medical Center Foundation from Mary Greeley Medical Center, McFarland Clinic, First American Bank, and Green Hills Health Care Center. The content and selection of speaker(s) is the responsibility of the Mary Greeley Medical Center for Continuing Medical Education Committee and not the sponsors of this program.
Continuing Education Credit
DO: Des Moines University (DMU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
No commercial interest company provided financial support for this continuing education activity.
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 1.00 AOA Category 2A